. Author manuscript; available in PMC: 2015 Oct 29.

Published in final edited form as: J Crit Care. 2015 Feb 7;30(3):619–623. doi: 10.1016/j.jcrc.2015.01.023

Table 2.

Risk of diuretic use during critical illness according to BMI

	Risk of diuretic use during critical illness according to BMI
	BMI groups					Per 5 kg/m² positive
	BMI < 18.5	18.5 ≥ BMI < 25	25 ≥ BMI < 30	30 ≥ BMI < 35	BMI ≥ 35	–
ICU diuretic use, n (%)	81 (43.1)	1071 (46.0)	1417 (51.8)	804 (54.4)	573 (57.8)
Unadjusted	0.89 (0.66–1.20)	1.00 (Ref.)	1.26 (1.13–1.41)	1.40 (1.23–1.59)	1.61 (1.38–1.87)	1.13 (1.09–1.17)
	P = .44		P < .001	P < .001	P < .001	P < .001
Model 1^a	0.82 (0.61–1.12)	1.00 (Ref.)	1.32 (1.18–1.48)	1.54 (1.34–1.76)	1.89 (1.62–2.20)	1.18 (1.14–1.22)
	P = .22		P < .001	P < .001	P < .001	P < .001
Model 2^b	0.81 (0.57–1.13)	1.00 (Ref.)	1.35 (1.20–1.53)	1.56 (1.35–1.80)	1.91 (1.61–2.26)	1.19 (1.14–1.23)
	P = .21		P < .001	P < .001	P < .001	P < .001

Adjusted for age, sex, and race.

Adjusted for age, sex, race, ICU type, admission SAPS, and Elixhauser comorbidities (all except for obesity).